Mark Berger
Förmögenhet: 1 254 $ per 2026-08-31
Förmögenhet: 1 254 $ per 2026-08-31
Mark S.
Berger is currently Chief Medical Officer at Genprex, Inc. since 2021.
Former positions include Senior Director-Oncology Clinical Development at Wyeth Pharmaceuticals LLC; Group Director-Clinical Oncology at GSK Plc from 2002 to 2007; Principal at the University of Pennsylvania; Vice President-Clinical Development at Gemin X Pharmaceuticals US, Inc. from 2007 to 2011; Chief Medical Officer at Deciphera Pharmaceuticals LLC from 2011 to 2013; Senior Vice President-Clinical Research at Kadmon Corp.
LLC from 2013 to 2017; and Chief Medical Officer at Actinium Pharmaceuticals, Inc. from 2017 to 2021.
Education includes undergraduate studies at Wesleyan University and a doctorate from The University of Virginia School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
GENPREX INC 0,04 % | 2026-04-15 | 338 ( 0,04 % ) | 1 254 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| GENPREX, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-09-27 |
| Företag | Position | Slut |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-09-24 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2017-01-01 |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Teknisk/Vetenskaplig/F&U Direktör | 2013-09-01 |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Företagsledare/Principal | 2011-06-01 |
| GSK PLC | Företagsledare/Principal | 2007-02-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Genprex, Inc.
Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The University of Virginia School of Medicine
The University of Virginia School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån